Abstract
Dipyridamole, previously reported to be an interferon (IFN) inducer in mice, was evaluated in 43 normal volunteers or cancer patients. At doses ranging from 150 mg orally to 887 mg intravenously, no serum antiviral activity suggesting IFN induction was observed.
Original language | English (US) |
---|---|
Pages (from-to) | 135-136 |
Number of pages | 2 |
Journal | Journal of Interferon Research |
Volume | 8 |
Issue number | 2 |
DOIs | |
State | Published - Apr 1988 |
ASJC Scopus subject areas
- Immunology
- Virology